Effect of dietary phosphate deprivation and supplementation of recipient mice on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice
Open Access
- 1 May 1992
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 7 (5), 523-530
- https://doi.org/10.1002/jbmr.5650070508
Abstract
The hypophosphatemic (Hyp) mouse is the murine homolog for human hypophosphatemic vitamin D-resistant rickets. We previously reported that bone cells isolated from normal and Hyp mice produced abnormal bone when transplanted intramuscularly into mutant mice. To assess the role of hypophosphatemia on bone formation in transplants, normal and Hyp mouse periostea were pair transplanted into control or phosphate (P)-supplemented Hyp mice and into control or P-deprived normal mice. The bone nodules formed in transplants after 2 weeks were characterized by measuring the thickness of the surrounding osteoid seams and the relative osteoid volume. P restriction in normal recipient mice impaired bone formation by transplanted normal cells and aggravated the defective bone formation by Hyp cells. The osteoid thickness and volume remained significantly higher in Hyp transplants than in normal cotransplants, however. P supplementation of Hyp recipient mice normalized bone formation by transplanted normal cells but not by Hyp cells. However, a marked decrease in osteoid thickness and volume was observed in Hyp transplants down to values observed in normal recipient mice. These results indicate that hypophosphatemia is not the only cause of abnormal bone formation in the Hyp mouse but that an osteoblast dysfunction contributes to the bone disease. These observations further support the concept that the osteoblast may be an important target for the Hyp mutation.Keywords
Funding Information
- American Society for Bone and Mineral Research
This publication has 23 references indexed in Scilit:
- Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.Journal of Clinical Investigation, 1985
- Healing of Bone Lesions with 1,25-Dihydroxyvitamin D3in the Young X-Linked Hypophosphatemic Male Mouse*Endocrinology, 1982
- Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant ricketsCalcified Tissue International, 1981
- Healing of rickets with phosphate supplementation in the hypophosphatemic male mouse.Journal of Clinical Investigation, 1981
- Bone Response to Phosphate Salts, Ergocalciferol, and Calcitriol in Hypophosphatemic Vitamin D-Resistant RicketsNew England Journal of Medicine, 1980
- Renal handling of phosphate in vivo and in vitro by the X-linked hypophosphatemic male mouse: Evidence for a defect in the brush border membraneKidney International, 1978
- Inadequate Bone Response to Phosphate and Vitamin D in Familial Hypophosphatemic Rickets (FHR)Published by Springer Nature ,1978
- Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets.Proceedings of the National Academy of Sciences, 1976
- Loss of a Parathyroid Hormone-Sensitive Component of Phosphate Transport in X-Linked HypophosphatemiaScience, 1972
- A GENETIC STUDY OF FAMILIAL HYPOPHOSPHATEMIA AND VITAMIN D RESISTANT RICKETS WITH A REVIEW OF THE LITERATUREMedicine, 1958